FDA Inspection 1192141 — Apitoria Pharma Private Limited

Apitoria Pharma Private Limited — FEI 3006370489

The FDA completed an inspection of Apitoria Pharma Private Limited on November 18, 2022 in Sangareddy. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 18, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sangareddy (India)